Skip to main content
Erschienen in: Journal of Cancer Survivorship 1/2008

01.03.2008

Survivorship issues following treatment completion—results from focus groups with Australian cancer survivors and health professionals

verfasst von: Michael Jefford, Emily Karahalios, Annabel Pollard, Carl Baravelli, Mariko Carey, Jennie Franklin, Sanchia Aranda, Penelope Schofield

Erschienen in: Journal of Cancer Survivorship | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

The number of cancer survivors is increasing dramatically. Many survivors report long-term psychosocial, physical and other consequences. To understand the issues faced by Australian cancer survivors we conducted focus groups with cancer patients and health professionals.

Methods

Patients were identified through a peer support program at a major cancer treatment center (Peter Mac). Health professionals were also recruited from Peter Mac. Focus groups followed a semi-structured format based on themes identified from the literature. Questions focused on treatment completion, and 1 year post-treatment. Participants were also asked to suggest solutions to address identified issues. Focus groups were taped, transcribed, cross-checked for accuracy, and analyzed independently.

Results

The most common needs (in terms of both frequency and intensity) reported at treatment completion by both survivors and professionals were dealing with fatigue, anxiety about cancer recurrence, others expecting you to be back to normal, having to create new expectations about physical ability, and anxiety about leaving the hospital system. The most common needs at 1 year were anxiety about check-ups and results, and going into early menopause. The most frequently suggested ways of meeting these perceived needs were reassuring survivors the way they feel is normal and putting them in contact with others who have been through the same experience.

Discussion

There was a high level of congruence in the themes identified by survivors and health professionals.

Implications for cancer survivors

These results provide a clear direction for the development of resources to support cancer survivors following treatment completion.
Literatur
1.
Zurück zum Zitat Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR). Cancer in Australia 2001. (AIHW cat. No. CAN 23) AIHW: Canberra (Cancer Services no. 28), 2004. Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR). Cancer in Australia 2001. (AIHW cat. No. CAN 23) AIHW: Canberra (Cancer Services no. 28), 2004.
2.
Zurück zum Zitat Institute of Medicine and National Research Council of the National Academies. From cancer patient to cancer survivor: Lost in transition. Washington: National Academy Press; 2006. Institute of Medicine and National Research Council of the National Academies. From cancer patient to cancer survivor: Lost in transition. Washington: National Academy Press; 2006.
6.
Zurück zum Zitat Loescher LJ, Welch-McCaffrey D, Leigh SA, et al. Surviving adult cancers. Part 1: Physiologic effects. Ann Intern Med. 1989;111(5):411–32.PubMed Loescher LJ, Welch-McCaffrey D, Leigh SA, et al. Surviving adult cancers. Part 1: Physiologic effects. Ann Intern Med. 1989;111(5):411–32.PubMed
7.
Zurück zum Zitat Welch-McCaffrey D, Hoffman B, Leigh SA, et al. Surviving adult cancers. Part 2: Psychosocial implications. Ann Intern Med. 1989;111(6):517–24.PubMed Welch-McCaffrey D, Hoffman B, Leigh SA, et al. Surviving adult cancers. Part 2: Psychosocial implications. Ann Intern Med. 1989;111(6):517–24.PubMed
8.
Zurück zum Zitat Lee-Jones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology 1997;6(2):95–105.PubMedCrossRef Lee-Jones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology 1997;6(2):95–105.PubMedCrossRef
9.
Zurück zum Zitat Thomas SF, Glynne-Jones R, Chait I, Marks DF. Anxiety in long-term cancer survivors influences the acceptability of planned discharge from follow-up. Psychooncology 1997;6(3):190–6.PubMedCrossRef Thomas SF, Glynne-Jones R, Chait I, Marks DF. Anxiety in long-term cancer survivors influences the acceptability of planned discharge from follow-up. Psychooncology 1997;6(3):190–6.PubMedCrossRef
10.
Zurück zum Zitat Holland JC, Reznik I. Pathways for psychosocial care of cancer survivors. Cancer 2005;104(11 Suppl):2624–37.PubMedCrossRef Holland JC, Reznik I. Pathways for psychosocial care of cancer survivors. Cancer 2005;104(11 Suppl):2624–37.PubMedCrossRef
11.
Zurück zum Zitat Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004;2004(32):57–71.CrossRef Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004;2004(32):57–71.CrossRef
12.
Zurück zum Zitat Weiss T. Correlates of posttraumatic growth in husbands of breast cancer survivors. Psychooncology 2004;13(4):260–8.PubMedCrossRef Weiss T. Correlates of posttraumatic growth in husbands of breast cancer survivors. Psychooncology 2004;13(4):260–8.PubMedCrossRef
13.
Zurück zum Zitat Short PF, Vasey JJ, Belue R. Work disability associated with cancer survivorship and other chronic conditions. Psychooncology 2007;17(1):91–7. Short PF, Vasey JJ, Belue R. Work disability associated with cancer survivorship and other chronic conditions. Psychooncology 2007;17(1):91–7.
14.
Zurück zum Zitat Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer 2005;103(6):1292–301.PubMedCrossRef Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer 2005;103(6):1292–301.PubMedCrossRef
15.
Zurück zum Zitat Schag CA, Ganz PA, Wing DS, et al. Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res. 1994;3(2):127–41.PubMedCrossRef Schag CA, Ganz PA, Wing DS, et al. Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res. 1994;3(2):127–41.PubMedCrossRef
16.
Zurück zum Zitat Northouse LL, Templin T, Mood D, Oberst M. Couples’ adjustment to breast cancer and benign breast disease: a longitudinal analysis. Psychooncology 1998;7(1):37–48.PubMedCrossRef Northouse LL, Templin T, Mood D, Oberst M. Couples’ adjustment to breast cancer and benign breast disease: a longitudinal analysis. Psychooncology 1998;7(1):37–48.PubMedCrossRef
17.
Zurück zum Zitat Dorval M, Guay S, Mondor M, et al. Couples who get closer after breast cancer: frequency and predictors in a prospective investigation. J Clin Oncol. 2005;23(15):3588–96.PubMedCrossRef Dorval M, Guay S, Mondor M, et al. Couples who get closer after breast cancer: frequency and predictors in a prospective investigation. J Clin Oncol. 2005;23(15):3588–96.PubMedCrossRef
18.
Zurück zum Zitat Couper J, Bloch S, Love A, et al. Psychosocial adjustment of female partners of men with prostate cancer: a review of the literature. Psychooncology 2006;15(11):937–53.PubMedCrossRef Couper J, Bloch S, Love A, et al. Psychosocial adjustment of female partners of men with prostate cancer: a review of the literature. Psychooncology 2006;15(11):937–53.PubMedCrossRef
19.
Zurück zum Zitat Couper JW, Bloch S, Love A, et al. The psychosocial impact of prostate cancer on patients and their partners. Med J Aust. 2006;185(8):428–32.PubMed Couper JW, Bloch S, Love A, et al. The psychosocial impact of prostate cancer on patients and their partners. Med J Aust. 2006;185(8):428–32.PubMed
20.
Zurück zum Zitat Andersen BL, Anderson B, deProsse C. Controlled prospective longitudinal study of women with cancer: I. Sexual functioning outcomes. J Consult Clin Psychol. 1989;57(6):683–91.PubMedCrossRef Andersen BL, Anderson B, deProsse C. Controlled prospective longitudinal study of women with cancer: I. Sexual functioning outcomes. J Consult Clin Psychol. 1989;57(6):683–91.PubMedCrossRef
21.
Zurück zum Zitat Maduro JH, Pras E, Willemse PH, de Vries EG. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev. 2003;29(6):471–88.PubMedCrossRef Maduro JH, Pras E, Willemse PH, de Vries EG. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev. 2003;29(6):471–88.PubMedCrossRef
22.
Zurück zum Zitat Penson DF, Feng Z, Kuniyuki A, et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol. 2003;21(6):1147–54.PubMedCrossRef Penson DF, Feng Z, Kuniyuki A, et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol. 2003;21(6):1147–54.PubMedCrossRef
23.
Zurück zum Zitat Ganz PA, Rowland JH, Desmond K, et al. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16(2):501–14.PubMed Ganz PA, Rowland JH, Desmond K, et al. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16(2):501–14.PubMed
24.
Zurück zum Zitat Karahalios A, Baravelli C, Carey M, et al. An audiovisual information resource to assist in the transition from completion of potentially curative treatment for cancer through to survivorship: A systematic development process. J Cancer Surviv. 2007;1(3):226–36.CrossRef Karahalios A, Baravelli C, Carey M, et al. An audiovisual information resource to assist in the transition from completion of potentially curative treatment for cancer through to survivorship: A systematic development process. J Cancer Surviv. 2007;1(3):226–36.CrossRef
25.
Zurück zum Zitat Schofield P, Carey M, Bonevski B, Sanson-Fisher R. Barriers to the provision of evidence-based psychosocial care in oncology. Psychooncology 2006;15(10):863–72.PubMedCrossRef Schofield P, Carey M, Bonevski B, Sanson-Fisher R. Barriers to the provision of evidence-based psychosocial care in oncology. Psychooncology 2006;15(10):863–72.PubMedCrossRef
26.
Zurück zum Zitat Chelf JH, Agre P, Axelrod A, et al. Cancer-related patient education: an overview of the last decade of evaluation and research. Oncol Nurs Forum. 2001;28(7):1139–47.PubMed Chelf JH, Agre P, Axelrod A, et al. Cancer-related patient education: an overview of the last decade of evaluation and research. Oncol Nurs Forum. 2001;28(7):1139–47.PubMed
27.
Zurück zum Zitat McPherson CJ, Higginson IJ, Hearn J. Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. J Public Health Med. 2001;23(3):227–34.PubMedCrossRef McPherson CJ, Higginson IJ, Hearn J. Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. J Public Health Med. 2001;23(3):227–34.PubMedCrossRef
28.
Zurück zum Zitat Fitch M. Supportive care for cancer patients. Hosp Q. 2000;3(4):39–46.PubMed Fitch M. Supportive care for cancer patients. Hosp Q. 2000;3(4):39–46.PubMed
Metadaten
Titel
Survivorship issues following treatment completion—results from focus groups with Australian cancer survivors and health professionals
verfasst von
Michael Jefford
Emily Karahalios
Annabel Pollard
Carl Baravelli
Mariko Carey
Jennie Franklin
Sanchia Aranda
Penelope Schofield
Publikationsdatum
01.03.2008
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 1/2008
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-008-0043-4

Weitere Artikel der Ausgabe 1/2008

Journal of Cancer Survivorship 1/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.